Belviq Cancer Risk: What You Need to Know

What is the cancer risk associated with Belviq? The FDA has ordered Belviq and Belviq XR withdrawn from the market after disturbing research suggests that Belviq may cause cancer. Belviq is a popular weight-loss drug that is prescribed to overweight adults to help prevent over-eating. In the wake of these findings, doctors and patients alike are asking about Belviq cancer risk, and attorneys are preparing Belviq cancer lawsuits on behalf of those affected.

In this blog post we’ll examine potential Belviq cancer risk associated with this popular weight-loss drug.

Is there a Belviq cancer risk?

Here’s what we know so far about the potential risk of cancer due to Belviq and Belviq XR (extended release):

In 2012, the FDA approved Belviq as a diet pill for treating overweight and obese adults. However, this approval was contingent on continued research that would examined potential Belviq cancer risk. Prior to approval, the FDA had expressed concern over findings that Belviq may increase patients’ risk of developing certain types of cancer.

In 2019, the results of a long-term study of Belviq cancer risk were released, and the findings were alarming. In the 5-year study following more than 12,000 patients, researchers found that those taking Belviq were at greater risk for developing cancer.

Based on the research, cancers potentially caused by Belviq include:

• Pancreatic cancer
• Colorectal cancer
• Lung cancer
• Breast cancer

Following the publication of research concerning potential Belviq cancer risk, the FDA ordered the manufacturer, Eisai, to withdraw Belviq from the market immediately.

“I take Belviq. Am I at risk of developing cancer?”

Recent research suggests that patients taking Belviq or Belviq XR may be at increased risk of developing certain types of cancer, including pancreatic cancer, colorectal cancer, and lung cancer. Other types of cancer may be involved, as well, and research is ongoing.

IMPORTANT: Due to potential Belviq cancer risk, the FDA has advised those taking Belviq to stop taking the medication and talk with their prescribing doctor immediately.

Those who have taken Belviq and been diagnosed with pancreatic, colorectal, lung, or breast cancer may be entitled to significant financial compensation.

Our Belviq cancer lawsuit attorneys would love to help you and your loved ones seek justice if we can.

For a FREE consultation with an experienced Belviq cancer lawyer regarding a potential Belviq cancer risk lawsuit, please call 1-800-525-7111 or complete the short form below.

There is no obligation, and there are absolutely no attorney fees unless we win your case and you receive financial compensation for potentially Belviq-linked cancer.

Please call 1-800-525-7111 today and let’s review your case.

“Belviq may be linked to serious cancer risk. If you’ve been diagnosed with cancer after taking Belviq or Belviq XR, now is the time to have your claim investigated.”

-Gene Riddle, managing partner and attorney, Riddle & Brantley

Based on research indicating potential Belviq cancer risk, you may qualify for a Belviq lawsuit if you meet the following criteria:

• You were prescribed Belviq (Lorcaserin) or Belviq XR, after June 2012
• You were diagnosed with pancreatic cancer, lung cancer, breast cancer or colorectal cancer after taking Belviq
• Your cancer diagnosis was 6 months or more after starting Belviq
• You are under 70 years of age

“Why Riddle & Brantley for my Belviq lawsuit?”

If you or a loved one has been diagnosed with cancer after taking Belviq or Belviq XR, you may have a claim for compensation and our attorneys would love to help you seek justice if we can.

Riddle & Brantley’s Belviq cancer lawsuit attorneys have been fighting to hold drug companies accountable for more than 35 years and we are committed to justice for all.

Our Belviq cancer risk lawyers are led by Gene Riddle, managing partner and attorney. Gene is a member of Million Dollar Advocates Forum, Multi-Million Dollar Advocates Forum, Super Lawyers, and The National Trial Lawyers Top 100. He is the recipient of the 2014 Litigator Award and has earned Martindale-Hubbell’s top-tier rating, AV Preeminent (see disclaimer below).

Together, Gene and Riddle & Brantely attorneys have recovered millions of dollars in compensation for injury victims across the United States, including our home state of North Carolina (see disclaimer below).

We’re proud of the results we’ve obtained for victims of dangerous drugs and we’d love to represent you in your Belviq cancer risk claim if we can.

For a FREE, no-obligation consultation with a Belviq cancer lawsuit lawyer, please call Riddle & Brantley at 1-800-525-7111.

Because we work on a contingency basis, you’ll only pay attorney fees if we win your case and recover financial compensation for you.

Please call 1-800-525-7111 today and let’s review your Belviq cancer claim.

“This settlement changed me and my family’s lives.”

–Linda B., Riddle & Brantley client

The FDA has withdrawn this medication due to serious potential Belviq cancer risk. If taking Belviq or Belviq XR resulted in your cancer diagnosis, we believe that’s wrong and we are committed to helping hold potentially negligent drug manufacturers accountable.

Justice Counts for victims of dangerous drugs. Please call 1-800-525-7111 today for a free consultation. We will listen to you, review your claim, and advise you on your best available legal options.

If you decide to hire us for your Belviq cancer risk lawsuit, we will fight tirelessly to secure the justice and compensation you need and deserve.

*** Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case.

*** Disclaimer: An attorney must meet certain requirements to join these organizations or receive these awards. For more information on Membership Criteria for Million Dollar Advocates Forum, Multi-Million Dollar Advocates Forum, Super Lawyers, The National Trial Lawyers Top 100, AV Preeminent by Martindale-Hubbell, and the Litigator Award, please visit our Membership Criteria page. These awards and memberships should not be construed as a promise or guarantee of a similar result. Each case is different and must be evaluated separately.